Company: PFSA
Filing Date: 2025-04-28
Form Type: S-4/A
Source: 0001213900-25-035718
Chunk: 19

Company: Profusa, Inc.
Filing Date: 2025-04-28
Form: S-4/A
Chunk 19
---
View Common Stock in connection with a shareholder meeting on December 21, 2023, related to the extension of NorthView’s business combination period from December 22, 2023, ultimately until as late as March 22, 2024. Additionally, the NorthView stockholders elected to redeem 95,394 public shares of NorthView Common Stock in connection with a shareholder meeting on March 21, 2024, related to the extension of NorthView’s business combination period monthly, for up to six months, from March 22, 2024, ultimately until as late as September 22, 2024. On September19, 2024, the NorthView stockholders previously elected to redeem 50,556 public shares of NorthView Common Stock in connection with the extension of NorthView’s business combination period monthly, for up to six months, from September22, 2024, ultimately until as late as March22, 2025 (together with the previous extensions, the “Extension”). On March21, 2025, the NorthView stockholders elected to redeem 532,958 public shares of NorthView Common Stock in connection with the extension of NorthView’s business combination period from March22, 2025, until June22, 2025. At the time of the stockholder vote on March21, 2025, NorthView’s stockholders redeemed 9.1% of the total outstanding shares. The aggregate of 18,820,439 public shares redeemed in connection with the Extension represented approximately 77.9% of the total NorthView shares of common stock outstanding following NorthView’s IPO and approximately 99.2% of the public shares previously outstanding. Immediately after the Closing, assuming no holder of Public Shares exercises its redemption rights, (i) Profusa shareholders will own, collectively, approximately 47.0% of the outstanding New Profusa Common Stock; (ii) NorthView’s public stockholders will retain an ownership interest of approximately 6.2% of the outstanding New Profusa Common Stock; (iii) the Sponsor (and its affiliates) will own approximately 13.6% of the outstanding New Profusa Common Stock, (iv) the Profusa senior secured convertible noteholders will own, collectively, approximately 14.1% of the outstanding New Profusa Common Stock, and (v) other stockholders will own approximately 19.1% of the outstanding New Profusa Common Stock, in each case, on a fully diluted net